Amanda Wilhite, PA-C

NPI: 1124367362
Total Payments
$136,303
2024 Payments
$48,772
Companies
21
Transactions
620
Medicare Patients
181
Medicare Billing
$15,661

Payment Breakdown by Category

Other$104,019 (76.3%)
Travel$12,374 (9.1%)
Food & Beverage$11,481 (8.4%)
Consulting$8,305 (6.1%)
Education$125.54 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $102,819 93 75.4%
Travel and Lodging $12,374 60 9.1%
Food and Beverage $11,481 454 8.4%
Consulting Fee $8,305 8 6.1%
Honoraria $1,200 1 0.9%
Education $125.54 4 0.1%

Top Paying Companies

Company Total Records Latest Year
Janssen Biotech, Inc. $43,105 135 $0 (2024)
Janssen Scientific Affairs, LLC $26,209 41 $0 (2023)
ABBVIE INC. $22,085 215 $0 (2024)
E.R. Squibb & Sons, L.L.C. $12,315 21 $0 (2024)
PFIZER INC. $9,972 48 $0 (2024)
Lilly USA, LLC $8,561 29 $0 (2024)
Eli Lilly and Company $4,641 8 $0 (2023)
Takeda Pharmaceuticals U.S.A., Inc. $3,935 34 $0 (2024)
Celgene Corporation $2,402 45 $0 (2024)
Celltrion USA Inc. $2,317 11 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $48,772 176 Janssen Biotech, Inc. ($31,889)
2023 $36,699 213 Janssen Biotech, Inc. ($10,594)
2022 $33,077 140 Janssen Scientific Affairs, LLC ($15,814)
2021 $17,756 91 Janssen Scientific Affairs, LLC ($10,352)

All Payment Transactions

620 individual payment records from CMS Open Payments — Page 1 of 25

Date Company Product Nature Form Amount Type
12/30/2024 ABBVIE INC. RINVOQ (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,125.00 General
Category: IMMUNOLOGY
12/23/2024 ABBVIE INC. SKYRIZI (Biological) Travel and Lodging In-kind items and services $11.32 General
Category: IMMUNOLOGY
12/21/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,675.00 General
Category: Immunology
12/20/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $8.01 General
Category: IMMUNOLOGY
12/17/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Travel and Lodging In-kind items and services $1,321.89 General
Category: Immunology
12/17/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Travel and Lodging In-kind items and services $467.19 General
Category: Immunology
12/17/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Travel and Lodging In-kind items and services $130.98 General
Category: Immunology
12/17/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Food and Beverage In-kind items and services $115.43 General
Category: Immunology
12/17/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $11.36 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
12/16/2024 ABBVIE INC. SKYRIZI (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,125.00 General
Category: IMMUNOLOGY
12/14/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,050.00 General
Category: Immunology
12/13/2024 Celltrion USA Inc. ZYMFENTRA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $372.00 General
Category: GASTROENTEROLOGY
12/13/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $16.05 General
Category: Immunology
12/11/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $30.66 General
Category: Immunology
12/09/2024 ABBVIE INC. Food and Beverage In-kind items and services $136.11 General
12/09/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $32.93 General
Category: Immunology
12/09/2024 ABBVIE INC. Food and Beverage In-kind items and services $25.19 General
12/09/2024 PFIZER INC. VELSIPITY (Drug) Food and Beverage In-kind items and services $13.54 General
Category: INFLAMMATION;PAIN
12/04/2024 Celltrion USA Inc. ZYMFENTRA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $372.00 General
Category: GASTROENTEROLOGY
12/04/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $102.40 General
Category: IMMUNOLOGY
12/03/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $8.61 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
11/23/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $11.29 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
11/22/2024 PFIZER INC. VELSIPITY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,375.00 General
Category: INFLAMMATION;PAIN
11/19/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $7.96 General
Category: IMMUNOLOGY
11/13/2024 Janssen Biotech, Inc. STELARA (Biological), TREMFYA Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $525.00 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 63 72 $22,608 $5,752
2022 1 52 54 $16,956 $4,387
2021 1 34 38 $11,932 $3,116
2020 2 32 35 $12,488 $2,406
Total Patients
181
Total Services
199
Medicare Billing
$15,661
Procedure Codes
5

All Medicare Procedures & Services

5 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 63 72 $22,608 $5,752 25.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 52 54 $16,956 $4,387 25.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 34 38 $11,932 $3,116 26.1%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 21 21 $6,594 $1,221 18.5%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 11 14 $5,894 $1,184 20.1%

About Amanda Wilhite, PA-C

Amanda Wilhite, PA-C is a Physician Assistant healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2013. The National Provider Identifier (NPI) number assigned to this provider is 1124367362.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Wilhite, PA-C has received a total of $136,303 in payments from pharmaceutical and medical device companies, with $48,772 received in 2024. These payments were reported across 620 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($102,819).

As a Medicare-enrolled provider, Wilhite has provided services to 181 Medicare beneficiaries, totaling 199 services with total Medicare billing of $15,661. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.

Practice Information

  • Specialty Physician Assistant
  • Location Houston, TX
  • Active Since 02/07/2013
  • Last Updated 07/21/2022
  • Taxonomy Code 363A00000X
  • Entity Type Individual
  • NPI Number 1124367362

Products in Payments

  • STELARA (Biological) $39,587
  • TREMFYA (Drug) $29,726
  • ZEPOSIA (Drug) $9,853
  • RINVOQ (Biological) $9,200
  • SKYRIZI (Biological) $8,110
  • XELJANZ (Drug) $7,125
  • HUMIRA (Biological) $4,537
  • ENTYVIO (Biological) $3,888
  • OMVOH (Drug) $3,644
  • ZYMFENTRA (Biological) $2,264
  • VELSIPITY (Drug) $2,246
  • DUPIXENT (Biological) $323.49
  • MONOFERRIC (Drug) $149.21
  • XIFAXAN (Drug) $91.47
  • DIFICID (Drug) $58.56
  • CREON (Drug) $51.34
  • VEGZELMA (Biological) $35.83
  • NOVASURE (Device) $29.69
  • GATTEX (Drug) $29.53
  • RELIZORB (Device) $24.48

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physician Assistant Doctors in Houston